SEC Form 4 · accession 0001683168-19-000538
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrey Semechkin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.51 | Feb 28, 2019 | A | 150,000 | A | — | Feb 28, 2029 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F13/36th of the shares underlying such options shall vest on May 28, 2019, and the remaining share in equal monthly installments over a period of 33 months.